Richard Taite of Cliffside Malibu on ESPN’s Break’n the Norm About Ryan Leaf’s Treatment Sentence
Richard Taite of Cliffside Malibu on ESPN’s Break’n the Norm about Ryan Leaf’s Treatment Sentence – Founder and CEO of Cliffside Malibu, Richard Taite, was a guest on nationally respected sports radio show Breakn’ the Norm with Les Norman to talk about the sentence former NFL football player Ryan Leaf received for his guilty plea to felony burglary and drug possession. The judge gave Leaf 9 months to be served in a drug treatment program, followed by a five-year suspended sentence. Taite provides his expert commentary on why the sentence is a positive one for Leaf, and discusses the ideal therapy plan. Cliffside Malibu is one of the world’s recognized top addiction treatment facilities for drug abuse and alcoholism, located in the pristine cliffs overlooking Malibu California’s famed beaches, just North of Los Angeles.
Women's Health in Juvenile Detention: How a Boys' System Is Failing Girls
Filed under: drug rehab treatment centers in washington state
When Jessica first entered the facility, brought in by police in handcuffs, she was given basically the same treatment as if she were a boy. First, she was given a full pat-down to check for contraband, like drugs or weapons. After showering and …
Read more on The Atlantic
The Little-Known Provision Of Obamacare That Could Have A Big, Bad Impact
Filed under: drug rehab treatment centers in washington state
Though seemingly small, according to the National Center for Policy Analysis the medical device tax would add approximately $ 3 billion annually to the taxes paid by medical device firms — a 100 percent increase. The result? For starters, the tax will …
Read more on WBUR
Study Finds KRAS Testing in Metastatic CRC Saves Money, but Questions Value …
Filed under: drug rehab treatment centers in washington state
Testing for gene mutations that hinder the ability of colorectal cancer patients to respond to anti-EGFR drugs is a cost-effective way of administering such pricey treatments, according to a study based on simulated modeling that was published this …
Read more on GenomeWeb